Smartceuticals

SmartCeuticals is an Italian biotechnology company focused on developing innovative therapeutic solutions for neurodegenerative disorders, particularly Parkinson's disease and Amyotrophic Lateral Sclerosis (ALS). The company utilizes a proprietary "Smart" delivery platform designed to enhance the bioavailability and brain penetration of established molecules, such as L-Dopa. By optimizing the pharmacokinetic profiles of these drugs, SmartCeuticals aims to reduce side effects and improve clinical outcomes for patients with chronic neurological conditions. Their research is deeply rooted in understanding autophagy and proteasome pathways in the central nervous system to address the underlying mechanisms of protein aggregation.